Show simple item record

dc.contributor.authorKaeser Pebernard, Stéphanie
dc.contributor.authorVionnet, Christine
dc.contributor.authorMari, Muriel
dc.contributor.authorSankar, Devanarayanan Siva
dc.contributor.authorHu, Zehan
dc.contributor.authorRoubaty, Carole
dc.contributor.authorMartínez Martínez, Esther
dc.contributor.authorZhao, Huiyuan
dc.contributor.authorSpuch Calvar, Miguel 
dc.contributor.authorPetri Fink, Alke
dc.contributor.authorRainer, Gregor
dc.contributor.authorSteinberg, Florian
dc.contributor.authorReggiori, Fulvio
dc.contributor.authorDengjel, Jörn
dc.date.accessioned2023-03-09T08:31:43Z
dc.date.available2023-03-09T08:31:43Z
dc.date.issued2022-08-10
dc.identifier.citationNature Communications, 13(1): 4685 (2022)spa
dc.identifier.issn20411723
dc.identifier.urihttp://hdl.handle.net/11093/4560
dc.description.abstractThe protein kinase mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth and proliferation, supporting anabolic reactions and inhibiting catabolic pathways like autophagy. Its hyperactivation is a frequent event in cancer promoting tumor cell proliferation. Several intracellular membrane-associated mTORC1 pools have been identified, linking its function to distinct subcellular localizations. Here, we characterize the N-terminal kinase-like protein SCYL1 as a Golgi-localized target through which mTORC1 controls organelle distribution and extracellular vesicle secretion in breast cancer cells. Under growth conditions, SCYL1 is phosphorylated by mTORC1 on Ser754, supporting Golgi localization. Upon mTORC1 inhibition, Ser754 dephosphorylation leads to SCYL1 displacement to endosomes. Peripheral, dephosphorylated SCYL1 causes Golgi enlargement, redistribution of early and late endosomes and increased extracellular vesicle release. Thus, the mTORC1-controlled phosphorylation status of SCYL1 is an important determinant regulating subcellular distribution and function of endolysosomal compartments. It may also explain the pathophysiology underlying human genetic diseases such as CALFAN syndrome, which is caused by loss-of-function of SCYL1.en
dc.description.sponsorshipNovo Nordisk Fonden | Ref. 0066384spa
dc.description.sponsorshipSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | Ref. CRSII5_189952spa
dc.description.sponsorshipSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | Ref. 310030_184781spa
dc.language.isoengspa
dc.publisherNature Communicationsspa
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titlemTORC1 controls Golgi architecture and vesicle secretion by phosphorylation of SCYL1en
dc.typearticlespa
dc.rights.accessRightsopenAccessspa
dc.identifier.doi10.1038/s41467-022-32487-7
dc.identifier.editorhttps://www.nature.com/articles/s41467-022-32487-7spa
dc.publisher.grupoinvestigacionTEAM NANO TECH (Grupo de Nanotecnoloxía)spa
dc.subject.unesco2302 Bioquímicaspa
dc.subject.unesco2410.07 Genética Humanaspa
dc.date.updated2023-03-09T08:30:10Z
dc.computerCitationpub_title=Nature Communications|volume=13|journal_number=1|start_pag=4685|end_pag=spa


Files in this item

[PDF]

    Show simple item record

    Attribution 4.0 International
    Except where otherwise noted, this item's license is described as Attribution 4.0 International